Literature DB >> 24043618

Analysis of the activities of RAD54, a SWI2/SNF2 protein, using a specific small-molecule inhibitor.

Julianna S Deakyne1, Fei Huang, Joseph Negri, Nicola Tolliday, Simon Cocklin, Alexander V Mazin.   

Abstract

RAD54, an important homologous recombination protein, is a member of the SWI2/SNF2 family of ATPase-dependent DNA translocases. In vitro, RAD54 stimulates RAD51-mediated DNA strand exchange and promotes branch migration of Holliday junctions. It is thought that an ATPase-dependent DNA translocation is required for both of these RAD54 activities. Here we identified, by high-throughput screening, a specific RAD54 inhibitor, streptonigrin (SN), and used it to investigate the mechanisms of RAD54 activities. We found that SN specifically targets the RAD54 ATPase, but not DNA binding, through direct interaction with RAD54 and generation of reactive oxygen species. Consistent with the dependence of branch migration (BM) on the ATPase-dependent DNA translocation of RAD54, SN inhibited RAD54 BM. Surprisingly, the ability of RAD54 to stimulate RAD51 DNA strand exchange was not significantly affected by SN, indicating a relatively smaller role of RAD54 DNA translocation in this process. Thus, the use of SN enabled us to identify important differences in the effect of the RAD54 ATPase and DNA translocation on two major activities of RAD54, BM of Holliday junctions and stimulation of DNA pairing.

Entities:  

Keywords:  ATPases; DNA Binding Protein; DNA Repair; Homologous Recombination; Small Molecules

Mesh:

Substances:

Year:  2013        PMID: 24043618      PMCID: PMC3814753          DOI: 10.1074/jbc.M113.502195

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  CLINICAL EFFECTS OF PROLONGED (CONTINUOUS) INFUSION OF STREPTONIGRIN (NSC-45383) IN ADVANCED CANCER.

Authors:  R D SULLIVAN; E MILLER; W Z ZUREK; F R RODRIGUEZ
Journal:  Cancer Chemother Rep       Date:  1963-12

2.  CHEMOTHERAPY WITH STREPTONIGRIN IN ADVANCED CANCER.

Authors:  M N HARRIS; T J MEDREK; F M GOLOMB; S L GUMPORT; A H POSTEL; J C WRIGHT
Journal:  Cancer       Date:  1965-01       Impact factor: 6.860

3.  Interaction of human recombination proteins Rad51 and Rad54.

Authors:  E I Golub; O V Kovalenko; R C Gupta; D C Ward; C M Radding
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

Review 4.  Happy Hollidays: 40th anniversary of the Holliday junction.

Authors:  Yilun Liu; Stephen C West
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

5.  On the origin of the toxicity of toxoflavin.

Authors:  H E LATUASAN; W BERENDS
Journal:  Biochim Biophys Acta       Date:  1961-09-30

6.  Catalysis of homologous DNA pairing by yeast Rad51 and Rad54 proteins.

Authors:  G Petukhova; S Stratton; P Sung
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

7.  Yeast Rad54 promotes Rad51-dependent homologous DNA pairing via ATP hydrolysis-driven change in DNA double helix conformation.

Authors:  G Petukhova; S Van Komen; S Vergano; H Klein; P Sung
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

8.  Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation.

Authors:  T L Tan; J Essers; E Citterio; S M Swagemakers; J de Wit; F E Benson; J H Hoeijmakers; R Kanaar
Journal:  Curr Biol       Date:  1999-03-25       Impact factor: 10.834

Review 9.  Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae.

Authors:  F Pâques; J E Haber
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

10.  Mutations in the RAD54 recombination gene in primary cancers.

Authors:  M Matsuda; K Miyagawa; M Takahashi; T Fukuda; T Kataoka; T Asahara; H Inui; M Watatani; M Yasutomi; N Kamada; K Dohi; K Kamiya
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

View more
  8 in total

Review 1.  Targeting the homologous recombination pathway by small molecule modulators.

Authors:  Fei Huang; Alexander V Mazin
Journal:  Bioorg Med Chem Lett       Date:  2014-05-06       Impact factor: 2.823

Review 2.  Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy.

Authors:  Sarah R Hengel; M Ashley Spies; Maria Spies
Journal:  Cell Chem Biol       Date:  2017-09-21       Impact factor: 8.116

Review 3.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

4.  A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repair.

Authors:  Or David Shahar; Alkmini Kalousi; Lital Eini; Benoit Fisher; Amelie Weiss; Jonatan Darr; Olga Mazina; Shay Bramson; Martin Kupiec; Amir Eden; Eran Meshorer; Alexander V Mazin; Laurent Brino; Michal Goldberg; Evi Soutoglou
Journal:  Nucleic Acids Res       Date:  2014-03-25       Impact factor: 16.971

5.  RAD54 N-terminal domain is a DNA sensor that couples ATP hydrolysis with branch migration of Holliday junctions.

Authors:  Nadish Goyal; Matthew J Rossi; Olga M Mazina; Yong Chi; Robert L Moritz; Bruce E Clurman; Alexander V Mazin
Journal:  Nat Commun       Date:  2018-01-02       Impact factor: 14.919

6.  Screening and purification of natural products from actinomycetes that affect the cell shape of fission yeast.

Authors:  Richard A Lewis; Juanjuan Li; Nicholas E E Allenby; Jeffery Errington; Jacqueline Hayles; Paul Nurse
Journal:  J Cell Sci       Date:  2017-08-03       Impact factor: 5.285

7.  RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells.

Authors:  Jennifer M Mason; Kritika Dusad; William Douglass Wright; Jennifer Grubb; Brian Budke; Wolf-Dietrich Heyer; Philip P Connell; Ralph R Weichselbaum; Douglas K Bishop
Journal:  Nucleic Acids Res       Date:  2015-03-12       Impact factor: 16.971

8.  RAD54 promotes alternative lengthening of telomeres by mediating branch migration.

Authors:  Emily Mason-Osann; Katherine Terranova; Nicholas Lupo; Ying Jie Lock; Lisa M Carson; Rachel Litman Flynn
Journal:  EMBO Rep       Date:  2020-04-26       Impact factor: 8.807

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.